SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients with Life-Threatening seizures that Won't stop
Disease control CompletedThis study tested a drug called SAGE-547 for people with super-refractory status epilepticus, a life-threatening condition where seizures continue despite strong medications. The trial included 132 participants aged 2 and older. The goal was to see if SAGE-547 could help patients…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 01, 2026 12:14 UTC
-
New hope for patients with Life-Threatening seizures?
Disease control CompletedThis study tested a drug called SAGE-547 in 25 people with super-refractory status epilepticus, a life-threatening condition where seizures do not stop with standard treatments. The main goal was to see if the drug is safe and tolerable when added to usual care. The study was com…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC